Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

Biosimilars present a necessary and timely opportunity for physicians, patients and healthcare systems. If suitably developed clinically, manufactured to the correct standards and used appropriately, they can positively impact on the financial sustainability of healthcare systems. A critical conside...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:ESMO Open
Hlavní autoři: Tabernero, Josep, Vyas, Malvika, Giuliani, Rosa, Arnold, Dirk, Cardoso, Fatima, Casali, Paolo G, Cervantes, Andres, Eggermont, Alexander MM, Eniu, Alexandru, Jassem, Jacek, Pentheroudakis, George, Peters, Solange, Rauh, Stefan, Zielinski, Christoph C, Stahel, Rolf A, Voest, Emile, Douillard, Jean-Yves, McGregor, Keith, Ciardiello, Fortunato
Médium: Artigo
Jazyk:Inglês
Vydáno: ESMO Open 2017
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5419210/
https://ncbi.nlm.nih.gov/pubmed/28848668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000142
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky